Mountain View, CA, United States of America

Timothy D Owens

This inventor holds 31 USPTO granted patents and 12 published patent applications and 14 EPO patents, primarily in Tyrosine Kinase Inhibitors. Top assignees: Roche Palo Alto LLC, Principia Biopharma Inc., Hoffmann-La Roche Inc.. Active years: 2009-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Timothy D Owens. Retrieved from https://idiyas.com/inventor/timothy-d-owens

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 31 

% Patents Active = 35.5

 

Average Co-Inventor Count = 4.4

ph-index = 9

Forward Citations = 371(Granted Patents)


Location History:

  • Mountain View, CA (US) (2009 - 2012)
  • Jersey City, NJ (US) (2012 - 2014)
  • San Carlos, CA (US) (2014 - 2020)
  • Pendleton, IN (US) (2022)
  • Redwood City, CA (US) (2017 - 2024)

Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Immunoproteasome Inhibitors
Tyrosine Kinase Inhibitors
Heterocycle
Multi-Reagent Slot Die Coating
Benzimidazole Derivatives
Bruton's Tyrosine Kinase
Pyrrolopyrazine Kinase
LMP7 Inhibitors
RLK Inhibitors
ITK Inhibitors
Dihydroindolone Derivatives
31 patents (USPTO):Explore Patents

Title: Pioneering Inventor: Timothy D Owens

Introduction:

Timothy D Owens is a visionary inventor hailing from Mountain View, CA (US) with an impressive track record in the field of patents. With 28 patents to his name, Owens has made significant contributions to the world of science and pharmaceuticals. His latest patents in immunoproteasome inhibitors showcase his commitment to advancements in medical research and treatment.

Latest Patents:

Owens' latest patents focus on compounds that act as immunoproteasome inhibitors, specifically targeting LMP2 and LMP7. These compounds, including those of Formula (I) or their pharmaceutically acceptable salts, have shown great promise in the treatment of diseases that can be addressed through the inhibition of immunoproteasomes. Additionally, Owens has developed pharmaceutical compositions containing these compounds and has outlined processes for their preparation.

Career Highlights:

Throughout his career, Timothy D Owens has been associated with esteemed companies such as Roche Palo Alto LLC and Principia Biopharma Inc. His tenure at these organizations has been marked by groundbreaking research and innovative developments in the pharmaceutical sector. Owens' dedication to scientific exploration and discovery has paved the way for novel advancements in medical treatments.

Collaborations:

During his professional journey, Owens has collaborated with notable individuals in the field, including coworkers Yan Lou and Rama K Kondru. These collaborations have been instrumental in driving forward the research and development initiatives spearheaded by Owens, leading to the successful patenting of several groundbreaking inventions.

Conclusion:

In conclusion, Timothy D Owens stands out as a pioneering inventor whose contributions have had a profound impact on the world of pharmaceuticals. With a stellar portfolio of patents and a passion for innovation, Owens continues to push the boundaries of scientific discovery, ultimately benefiting individuals worldwide through his groundbreaking inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…